Project Grant R01AG097947
- Federal Grant Award Summary Harvard Medical School received a $125,901 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded August 15, 2025, with a completion date of May 31, 2027. The grant supports research investigating cell-type-specific dysregulation and genetic control of alternative polyadenylation (APA) in neurodegenerative disease, specifically Alzheimer's disease and Parkinson's disease. The research delivers novel...
- This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
- Federal Grant Award Summary The National Institute on Aging awarded a $122,858 Project Grant to Harvard T.H. Chan School of Public Health on June 16, 2025, under the Aging Research program (CFDA 93.866) for research titled "Molecular Profiles for Mortality Risk and Longevity: A Multiomics Approach." Through this award, Principal Investigator Dr. Fenglei Wang will conduct a K99/R00 career development project investigating the relationship between genetic factors, plasma metabolomic...
- Federal Project Grant Award Summary The National Institute on Aging awarded President and Fellows of Harvard College (operating as Harvard Medical School) $478,624 under the Aging Research program (CFDA 93.866) to develop cross-platform fluorescent reporter tools for measuring the activity of the 26S proteasome and the VCP/P97 complex. These protein degradation regulators are critical to understanding aging and age-related neurodegenerative diseases, including Alzheimer's disease and related...
- The National Institute on Aging (NIA) awarded a Project Grant totaling $2,283,522 to Harvard T.H. Chan School of Public Health on September 17, 2024 under the NIA's Aging Research Federal Grant Program (CFDA 93.866). This 3-year project aims to evaluate the impact of a new Centers for Medicare and Medicaid Services (CMS) policy, the "80% Rule," on enrollment changes of Medicare-Medicaid dual eligible beneficiaries from non-integrated "look-alike" plans into integrated care...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $486,000 to Hebrew Rehabilitation Center (doing business as Hebrew Senior Life) on September 10, 2025, under the Aging Research program (CFDA 93.866) to support a research project titled "Strengthening Recovery - Integrating Intrinsic Capacity Care into Post-Acute Skilled Nursing Facilities." The project, which extends through June 30, 2030, will develop and test an adapted version of the World Health...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Beth Israel Deaconess Medical Center $191,193.00 under the Aging Research program (CFDA 93.866) for a project grant beginning September 9, 2025, and concluding May 31, 2030. Principal Investigator Dr. Adrian Haimovich will develop and pilot test the Serious Illness Communication intervention for the Emergency Department (SIC-ED), an electronic health record (EHR)-embedded intervention designed to help emergency...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $3.69 million Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) to develop specialized Large Language Models (LLMs) optimized for comparative effectiveness research in Alzheimer's disease and related dementias. The four-year project, which commenced September 15, 2025 and concludes September 14, 2029, addresses a critical gap in real-world evidence generation by...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Icahn School of Medicine at Mount Sinai $422,500 through the Aging Research program (CFDA 93.866) to conduct a two-year research project (September 1, 2025 – August 31, 2027) investigating out-of-pocket spending (OOPS) and burdensome care for older adults with serious illness. The research will examine how insurance generosity—a currently underexplored policy-modifiable factor—influences high OOPS and associated...
Federal Grant Award Summary The National Institute on Aging (NIA) awarded Harvard Medical School a Project Grant totaling $683,924 on February 1, 2026, under the Aging Research program (CFDA 93.866) to conduct rigorous empirical research examining the effects of private equity (PE) acquisitions on patient outcomes and healthcare utilization in U.S. hospices. The five-year project, scheduled for completion on January 31, 2031, will deliver a comprehensive analysis of how PE-driven ownership changes in hospice facilities influence patient selection, service delivery patterns, and Medicare spending, utilizing a novel dataset linking hospice PE acquisitions to 100% Centers for Medicare & Medicaid Services Medicare claims data spanning 2016-2018. The research employs a quasi-experimental hypothesis-driven approach to investigate key mechanisms through which PE firms may alter hospice operations, including patient risk selection, length of stay patterns, discharge rates, and shifts toward lower-cost care modalities. This work addresses a critical evidence gap in healthcare policy, as approximately half of U.S. hospices have transitioned from nonprofit to for-profit status over the past two decades with PE driving recent increases, yet rigorous evidence on PE's clinical and economic effects in hospice remains sparse. The project's findings are intended to inform policymakers and healthcare administrators regarding the consequences of PE acquisitions in a sector serving 67 million Medicare beneficiaries and accounting for approximately one-quarter of Medicare spending, leveraging existing evidence from other healthcare delivery settings demonstrating that PE acquisitions frequently correlate with increased mortality, adverse events, and healthcare expenditures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $683.9k | 1/26/26 |